Regeneron

News

Regeneron begins late-stage trial testing COVID-19 antibody ...

Regeneron has begun a late-stage clinical trial testing its double “antibody cocktail” as a preventive treatment for COVID-19.

News

Blood sample with respiratory coronavirus positive

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi

News

Regeneron gets closer to ISA Pharma with new immuno-oncology...

Regeneron has doubled down in its ongoing collaboration with ISA Pharma, taking a bigger stake in the Dutch biotech and cueing up a third trial of their immuno-oncology combina

News

Regeneron begins trials of COVID-19 antibody cocktail

Regeneron has said it has begun clinical trials of its antibody cocktail therapy for COVID-19, as pharma companies continue their search for treatments as the pandemic continues to cause ha

News

Sanofi sheds Regeneron stake, but insists collaboration is u...

Sanofi and Regeneron’s once close relationship has been become a little more distant over the last couple of years, and the process continued this week after Sanofi said it wil

News

Sanofi and Regeneron eye challenge to Merck & Co in first li...

Sanofi and Regeneron could mount a challenge to Merck & Co’s Keytruda in untreated advanced lung cancer with their cancer immunotherapy latecomer Libtayo following new phase 3 results.

Regeneron begins late-stage trial testing COVID-19 antibody ...

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Regeneron gets closer to ISA Pharma with new immuno-oncology...

Regeneron begins trials of COVID-19 antibody cocktail

Sanofi sheds Regeneron stake, but insists collaboration is u...

Sanofi and Regeneron eye challenge to Merck & Co in first li...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Regeneron

Editor's Picks